REG - Zotefoams PLC - Result of the 2024 Annual General Meeting

ZotefoamsAnnouncement

22/05/2024 14:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240522:nRSV5073Pa&default-theme=true

RNS Number : 5073P  Zotefoams PLC  22 May 2024

Zotefoams plc

('the Company')

 

Result of the 2024 Annual General Meeting

 

22 May 2024 - The Company announces that at its Annual General Meeting held on
22 May 2024 at its offices at 675 Mitcham Road, Croydon CR9 3AL, all of the
resolutions tabled at the meeting were passed on a poll vote. Resolutions 1 to
13 inclusive were passed as ordinary resolutions and resolutions 14 to 17
inclusive were passed as special resolutions.

 

The total number of ordinary shares in issue in relation to the AGM is
48,846,234. Votes were cast by shareholders in respect of 28,504,200 ordinary
shares amounting to 58.35% of the issued share capital.

 

The votes cast* were recorded as follows:

 

 Resolution                                                                               For         % of votes cast  Against    % of votes cast  Votes Withheld
 1.      To receive the Annual Report of the Company for the year ended 31 December       28,500,344  100.00           -          0.00             3,856
         2023
 2       To approve the Annual Statement by the Chair of the Remuneration Committee and   27,375,656  96.07            1,121,323  3.93             7,221
         the Annual Report on Remuneration for the year ended 31 December 2023 set out
         on pages 90 to 103 of the Annual Report.
 3       To declare a final dividend for the year ended 31 December 2023 of 4.90 pence    28,504,200  100.00           -          0.00             -
         per ordinary share, such dividend to be payable on 3 June 2024 to shareholders
         on the register of members of the Company at the close of business on 3 May
         2024.
 4       To re-elect L Drummond as a Director.                                            27,361,612  95.99            1,141,866  4.01             722
 5.      To elect R M Cox as a Director.                                                  28,383,334  100.00           146        0.00             120,720
 6.      To re-elect G C McGrath as a Director.                                           28,500,198  100.00           146        0.00             3,856
 7       To re-elect J D Carling as a Director.                                           28,234,204  99.06            269,274    0.94             722
 8.      To re-elect D G Robertson as a Director.                                         28,231,068  99.06            269,274    0.94             3,858
 9.      To elect M S Swift as a Director.                                                28,382,581  100.00           899        0.00             120,720
 10.     To re-elect C A Wall as a Director.                                              28,230,544  99.04            272,935    0.96             721
 11.     To re-appoint PKF Littlejohn LLP as Auditor of the Company.                      28,380,834  99.99            2,646      0.01             120,720
 12.     To authorise the Audit Committee to determine the Auditor's remuneration.        28,500,834  100.00           146        0.00             3,220
 13.     To authorise the Directors to allot shares.                                      28,365,815  99.56            124,346    0.44             14,039
 14.     To authorise the Directors to allot equity securities for cash.                  28,374,893  99.57            123,682    0.43             5,625
 15.     To authorise the Directors, in addition to resolution 14, to allot further       28,378,719  99.57            122,556    0.43             2,925
         equity securities for financing (and refinancing) purposes only.
 16.     To authorise market purchases of shares.                                         28,501,980  99.99            2,220      0.01             -
 17.     That a general meeting other than an annual general meeting may be called on     27,637,020  96.96            867,179    3.04             1
         not less than 14 clear days' notice.

 

*  Total votes cast excludes votes withheld as a vote withheld is not a vote
in law.

 

Further details of the resolutions (including the text of the resolutions) are
given in the Notice of the 2024 Annual General Meeting, which is on page 161
of the 2023 Annual Report and which is also available on the Company's
website.

 

Pursuant to Listing Rule 9.6, the Company also confirms that a copy of all
relevant resolutions passed at its AGM will shortly be made available for
public inspection via the National Storage Mechanism.

 

Lydia Harratt

Group Company Secretary

Zotefoams plc

020 8664 1600

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology
delivering optimal material solutions for the benefit of society. Utilising a
variety of unique manufacturing processes, including environmentally friendly
nitrogen expansion for lightweight AZOTE(®) polyolefin and ZOTEK(®)
high-performance foams, Zotefoams sells to diverse markets worldwide.
Zotefoams uses its own cellular materials to manufacture T-FIT(®) advanced
insulation for demanding industrial markets. Zotefoams also owns and licenses
patented microcellular foam technology to reduce plastic use in extrusion
applications and for ReZorce(®) mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites
in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam
products manufacture and conversion), Massachusetts, USA, Stilling, Denmark
(microcellular foam technology) and Jiangsu Province, China (T-FIT).

www.zotefoams.com (http://www.zotefoams.com)

AZOTE(®), ZOTEK(®), ReZorce(®) and T-FIT(®) are registered trademarks of
Zotefoams plc.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGFLFIVEIIFFIS